DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stent Market - Focus on Bioabsorbable Stents Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.
Global Coronary Artery Stent - Focus on Bioabsorbable Stents Market Outlook 2024 provides information on the current scenario, market outlook of the global coronary artery stents market with detailed analysis of bioresorbable stents.
FDA has recently approved much-awaited first dedicated coronary bifurcated stent for treatment of cardiovascular diseases.
The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global coronary artery stents market. The report has been segmented as following:
Market Segments
- Coronary Artery Stents
- Bioresorbable stents
Companies Coverage
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- REVA Medical
- Biotronik, Inc.
Key Topics Covered:
1. Executive Summary
2. Research Methodology
3. Coronary Artery Stents
4. Market Analysis
5. Bioresorbable Stents
6. Regional Analysis
7. Market Dynamics
8. Competitive Landscape
9. Company Profiles
- Abbott Laboratories
- Biotronik Inc
- Boston Scientific Corporation
- Medtronic PLC
- REVA Medical
